2012
DOI: 10.1016/j.recesp.2012.03.008
|View full text |Cite
|
Sign up to set email alerts
|

Prevalencia y características clínicas de la enfermedad arterial periférica en la población general del estudio Hermex

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
7
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 36 publications
(8 citation statements)
references
References 30 publications
(17 reference statements)
1
7
0
Order By: Relevance
“…The results of our study show that the prevalence of PAD is low in comparison with other international population-based studies [ 28 ], but similar to that found in the Hermex Study carried out in Badajoz (Spain) [ 29 ]. A recent systematic review for Peripheral Arterial Disease Research Coalition including 34 community-based studies [ 30 ] evidenced that prevalence of PAD ranged between 7.3–11.8% for women aged 50–74 years and between 6.4–12.1% for men aged 50–74 years among high-income countries.…”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation
“…The results of our study show that the prevalence of PAD is low in comparison with other international population-based studies [ 28 ], but similar to that found in the Hermex Study carried out in Badajoz (Spain) [ 29 ]. A recent systematic review for Peripheral Arterial Disease Research Coalition including 34 community-based studies [ 30 ] evidenced that prevalence of PAD ranged between 7.3–11.8% for women aged 50–74 years and between 6.4–12.1% for men aged 50–74 years among high-income countries.…”
Section: Discussionsupporting
confidence: 88%
“…It is commonly accepted that men have a higher prevalence of PAD than women until the seventh decade of life [ 16 , 29 , 36 ]. However, in our study, the PAD prevalence was lower in women in comparison with men for each age group.…”
Section: Discussionmentioning
confidence: 99%
“…These rates are similar to those reported in other population-based studies in the USA and Europe that include a minimum age cut-off. In both the US Life Line Screening programme (participants aged ≥40 years; study years 2003–2008) 18 and the Spanish HERMEX study (participants aged ≥50 years; study years: 2007–2009), 19 PAD prevalence was 3.7%. Slightly higher prevalences of 7.6% and 5.8%, respectively, were reported in a Spanish primary healthcare study (participants aged ≥50 years; study years 2006–2008) 20 and the German Heinz Nixdorf Recall study (participants aged ≥45 years; study years 2000–2003).…”
Section: Discussionmentioning
confidence: 99%
“…Three different groups have studied it using the ankle-brachial index (ABI) with similar methodology. They have found PAD prevalence between 3.7% and 7.6% [2-5]. …”
Section: Introductionmentioning
confidence: 99%